Teva Pharmaceutical Industries Ltd - Company Profile
Powered by 
All the data and insights you need on Teva Pharmaceutical Industries Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Teva Pharmaceutical Industries Ltd Strategy Report
- Understand Teva Pharmaceutical Industries Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Teva Pharmaceutical Industries Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Teva Pharmaceutical Industries Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 25 Jul 2022 | Lorem |
| Sunovion, Teva/MedinCell and Minerva drive expert interest with upcoming catalysts in the schizophrenia landscape | 19 Oct 2021 | William Newton |
| AbbVie’s atogepant, Biohaven’s Nurtec ODT for preventive migraine may not cause approved mAbs as many headaches as market expects, experts say | 23 Apr 2021 | William Newton |
| LoA Update: Teva Pharmaceutical’s extended-release risperidone for schizophrenia sees 5-point boost in regulatory potential following positive Phase III study | 30 Mar 2021 | William Newton |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer